Molecular structure pattern

Chronic Lymphocytic Leukemia References

Last updated: 23 September 2026
Reviewed by
  1. Kawamata N, Moreilhon C, Saitoh T, et al. Genetic differences between Asian and Caucasian chronic lymphocytic leukemia. Int J Oncol. 2013 Aug;43(2):561-565. doi:10.3892/ijo.2013.1966. Accessed 12 May 2016. PMID: 23708256
  2. National Institute for Health and Care Excellence (NICE). NICE pathways: leukaemia. NICE. http://pathways.nice.org.uk. 2016. Accessed 25 Apr 2016.
  3. Negrin RS, Rai KR. Hematopoietic cell transplantation in chronic lymphocytic leukemia. UpToDate. https://www.uptodate.com/. Apr 2016. Accessed 16 May 2016.
  4. ESMO Guidelines Committee. eUpdate - chronic lymphocytic leukaemia treatment recommendations. ESMO. http://www.esmo.org/. Jun 2017.
  5. Hallek M, Cheson BD, Catovsky D, et al. Guidelines for diagnosis, indications for treatment, response assessment and supportive management of chronic lymphocytic leukemia. Blood. 2018 Mar. doi: 10.1182/blood-2017-09-806398. PMID: 29540348
  6. Rai KR, Stilgenbauer S. Evaluating response to treatment of chronic lymphocytic leukemia. UpToDate. https://www.uptodate.com/. Apr 2018.
  7. Rai KR, Stilgenbauer S. Selection of initial therapy for symptomatic or advanced chronic lymphocytic leukemia. UpToDate. https://www.uptodate.com/. Apr 2018.
  8. A Mir M. Chronic lymphocytic leukemia (CLL). Medscape. https://emedicine.medscape.com/. 07 Feb 2020.
  9. Brander D, Islam P, Barrientos JC. Tailored treatment strategies for chronic lymphocytic leukemia in a rapidly changing era. Am Soc Clin Oncol Educ Book. 2019 Jan;39:487-498. doi: 10.1200/EDBK_238735. PMID: 31099686
  10. Kotiah S. Chronic lymphocytic leukemia treatment protocols. Medscape. https://emedicine.medscape.com/. 25 Nov 2024. Accessed 17 May 2022.
  11. National Cancer Institute. Chronic lymphocytic leukemia treatment (PDQ®) - health professional version. National Cancer Institute. https://www.cancer.gov/. 22 Jan 2020.
  12. Parikh SA. Chronic lymphocytic leukemia treatment algorithm 2018. Blood Cancer J. 2018;8:93. doi: 10.1038/s41408-018-0131-2.
  13. Schuh AH, Parry-Jones N, Appleby N, et al. Guideline for the treatment of chronic lymphocytic leukemia: a British Society for Haematology guideline. Br J Haematol. 2018 Aug;182(3):344-359. doi: 10.1111/bjh.15460. Accessed 07 Feb 2020. PMID: 30009455
  14. Eichhorst B, Robak T, Montserrat E, et al; ESMO Guidelines Committee. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020 Oct:S0923-7534(20)42469-X. doi: 10.1016/j.annonc.2020.09.019. PMID: 33091559
  15. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology (NCCN guidelines): chronic lymphocytic leukemia/small lymphocytic lymphoma. Version 3.2025. NCCN. https://www.nccn.org/. 02 Apr 2025. Accessed 27 May 2025.
  16. Rhodes JM, Barrientos JC. Chemotherapy-free frontline therapy for CLL: is it worth it? Hematology Am Soc Hematol Educ Program. 2020 Dec;2020(1):24-32. doi: 10.1182/hematology.2020000085. PMID: 33275668
  17. Hampel PJ, Parikh SA. Chronic lymphocytic leukemia treatment algorithm 2022. Blood Cancer J. 2022 Nov;12(11):161. doi: 10.1038/s41408-022-00756-9. PMID: 36446777
  18. National Cancer Institute (NCI). Chronic lymphocytic leukemia treatment - health professional version (PDQ®). NCI. http://www.cancer.gov/. 30 Jun 2023.
  19. Thompson PA, Tam CS. Pirtobrutinib: a new hope for patients with BTK inhibitor-refractory lymphoproliferative disorders. Blood. 2023 Jun;141(26):3137-3142. doi: 10.1182/blood.2023020240. PMID: 37156004
  20. Tse E, Kwong YL, Goh YT, et al. Expert consensus on the management of chronic lymphocytic leukaemia in Asia. Clin Exp Med. 2023 Feb. doi: 10.1007/s10238-023-01007-2. PMID: 36795237
  21. Walewska R, Parry-Jones N, Eyre TA, et al. Guideline for the treatment of chronic lymphocytic leukaemia. Br J Haematol. 2022 Jun;197(5):544-557. doi: 10.1111/bjh.18075. PMID: 35313007
  22. Eichhorst B, Ghia P, Niemann CU, et al. ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia. Ann Oncol. 2024 Sep;35(9):762-768. doi: 10.1016/j.annonc.2024.06.016. Accessed 14 Aug 2024. PMID: 38969011
  23. American Cancer Society (ACS). Key statistics for chronic lymphocytic leukemia (CLL). ACS. https://www.cancer.org/. 2026.
  24. Cancer Research UK. Chronic lymphocytic leukaemia (CLL) incidence statistics. Cancer Research UK. https://www.cancerresearchuk.org/. 2026.
  25. Chisti MM. Chronic lymphocytic leukemia (CLL) medication. Medscape. https://reference.medscape.com/. Aug 2025.
  26. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology (NCCN guidelines): chronic lymphocytic leukemia/small lymphocytic lymphoma. Version 1.2027. NCCN. https://www.nccn.org/. 20 Aug 2026.
  27. Ou Y, Long Y, Ji L, et al. Trends in disease burden of chronic lymphocytic leukemia at the global, regional, and national levels from 1990 to 2019, and projections until 2030: a population-based epidemiologic study. Front Oncol. 2022 Mar;12:840616. doi: 10.3389/fonc.2022.840616. PMID: 35359356